Federal Supply Schedule 36F79720D0177

Award Date 8/1/20
Last Date to Order 7/31/25
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule (FSS) contract to Genericus, Inc. under the Pharmaceuticals and Drugs (FSS-61-IB) FSS master schedule. The contract, valued at up to $225,000.00, enables the procurement of drugs, pharmaceuticals, and hematology-related products. As an FSS contract, this is a multiple award vehicle that allows for indefinite delivery of the specified products and services...
This Federal Supply Schedule (FSS) contract was awarded by the U.S. Department of Veterans Affairs (VA) to H2-Pharma LLC, a for-profit limited liability company, to provide pharmaceuticals and hematology-related products. The contract has a ceiling value of $225,000.00 and a period of performance from October 1, 2018 to October 1, 2025. The FSS contract, part of the Pharmaceuticals and Drugs (FSS-61-IB) schedule, is a multiple award vehicle that allows federal agencies to procure the...
This is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Apnar Pharma, LP, a minority-owned small disadvantaged business. The contract, with a ceiling value of $2,225,000.00, is for the provision of pharmaceutical and hematology-related products under FSS Schedule 65 IB. The contract has a period of performance from June 15, 2021 to June 14, 2026. As an FSS contract, it allows for the placement of task orders by federal agencies for the...
This Federal Supply Schedule contract with the Department of Veterans Affairs (VA) is for the procurement of drugs, pharmaceuticals, and hematology-related products. The prime contractor is Biocon Biologics Inc., a foreign-owned for-profit manufacturer of goods. The contract has a ceiling value of $750,000.00 and a period of performance from March 1, 2024 to February 28, 2029. As a Federal Supply Schedule contract, this is a multiple award, indefinite delivery vehicle that allows federal...
The Federal Supply Schedule (FSS) contract 36F79718D0461 was awarded to Prime Contractor Para Pro LLC, a small disadvantaged business and veteran-owned manufacturer of goods, to provide pharmaceuticals and related hematology products. The contract has a $250,000 ceiling value and a performance period ending on May 31, 2025. This multiple award FSS contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule and was awarded by the Department of Veterans Affairs, Veterans...
This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs (VA) to Exela Pharma Sciences LLC, is for the procurement of pharmaceuticals, drugs, and hematology-related products under FSS-61-IB. The contract has a ceiling value of $3,030,000.00 and a period of performance through September 28, 2024. As a multiple-award schedule contract, this FSS allows the VA and other eligible federal agencies to issue task orders for a wide range of pharmaceutical and drug...
This Federal Supply Schedule (FSS) contract was awarded by the U.S. Department of Veterans Affairs (VA) to G1 Therapeutics, Inc. for the provision of pharmaceutical and drug products. The contract has a ceiling value of $2,250,000.00 and a period of performance through July 14, 2026. The contract falls under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule and allows for the delivery of a broad range of drug and hematology-related products to the VA and its related healthcare...
The Federal Supply Schedule (FSS) contract awarded to Fera Pharmaceuticals, LLC is for the procurement of pharmaceutical drugs, pharmaceuticals, and hematology-related products. The prime contractor, Fera Pharmaceuticals, is a woman-owned small business that supplies the Department of Veterans Affairs (VA) and other government agencies with these products. The FSS contract, valued at up to $450,000.00, was awarded by the VA's Veterans Health Administration Veterans Integrated Service Network...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government, to Pharmaessentia USA Corp, a foreign-owned for-profit organization. The contract is for the provision of Drugs, Pharmaceuticals, & Hematology Related Products under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule. The contract has a ceiling value of $6,000,000.00 and a period of performance from June 1, 2022 to May 31,...
This is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Enzyvant Therapeutics Inc. The contract is for pharmaceutical and hematology-related products under Schedule 65 I B of the FSS program. The contract has a ceiling value of $25,000.00 and a period of performance from January 1, 2023 to June 30, 2023. As an FSS contract, this is a multiple award vehicle allowing other federal agencies to place orders against the schedule. The contract was awarded...

This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs (VA) to BeiGene USA, Inc., provides for the procurement of pharmaceutical and hematology-related products. The contract has a ceiling value of $700,000.00 and a period of performance through July 31, 2025.

The FSS contract, part of the Pharmaceuticals and Drugs (FSS-61-IB) schedule, enables the VA to order a variety of pharmaceutical and hematology products from the contractor as needed. As a multiple award contract, it provides the VA with flexibility to select the most appropriate vendor and product for its requirements. The contract does not utilize any set-asides, and the contractor is a foreign-owned, for-profit manufacturer of goods.

Generated 3/19/25, 9:57 AM